Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Papillary Dermis01:11

Papillary Dermis

Dermis
The dermis might be considered the "core" of the integumentary system, as distinct from the epidermis and hypodermis. It contains blood and lymph vessels, nerves, and other structures, such as hair follicles and sweat glands. The dermis is made of two layers of connective tissue that comprise an interconnected mesh of elastin and collagenous fibers, produced by fibroblasts.
Papillary Layer
The papillary layer is made of loose, areolar connective tissue, which means the collagen and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epicardial extracellular vesicles modulate gene expression following ischemia-reperfusion injury in heart-on-a-chip.

Materials today. Bio·2026
Same author

Guiding the spatial organization of engineered heart tissues.

Advanced drug delivery reviews·2026
Same author

Mapping the miRNA landscape of primitive macrophage extracellular vesicles highlights their pro-vasculogenic effects in engineered human cardiac tissue.

APL bioengineering·2026
Same author

Advanced physiological maturation of human iPSC-derived cardiomyocytes using an algorithm-directed optimization of defined media components.

Nature communications·2026
Same author

From conventional screening to self-driving discovery: Organ-on-Chip platforms as engines for AI-guided nanomedicine.

Advanced drug delivery reviews·2026
Same author

Heart-on-a-chip and vasculature-on-a-chip platforms as models of cardiovascular disease.

Nature reviews. Cardiology·2026
Same journal

Targeted co-delivery of docetaxel and plumbagin via oxidative priming enhances chemoradiotherapy in non-small cell lung cancer.

Materials today. Bio·2026
Same journal

Elastic scaffolds reinforced stem cell-laden collagen-derived hybrid hydrogels to engineer 3D anisotropic cellular microenvironment.

Materials today. Bio·2026
Same journal

Cantharidin-manganese based cocktail nanoplatform Co-activating ferroptosis and STING for enhanced HCC immunotherapy.

Materials today. Bio·2026
Same journal

Photocontrolled biomimetic PEEK scaffold with black phosphorus-strontium ion cascade release for vascularized bone regeneration.

Materials today. Bio·2026
Same journal

Reprogramming macrophage metabolism for cardiovascular therapy: From molecular pathways to precision nanomedicine.

Materials today. Bio·2026
Same journal

Light-assisted 3D bioprinting of tough hydrogels in biomedical applications.

Materials today. Bio·2026
See all related articles

Related Experiment Video

Updated: Jul 6, 2026

Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale
08:49

Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale

Published on: May 28, 2021

11.5K

A dermis-on-a-chip model for compound screening.

Dhana Abdo1, Yimu Zhao2, Sargol Okhovatian3,4

  • 1Department of Chemical Engineering and Applied Chemistry, University of Toronto, 27 King's College Circle, Toronto, ON, M5S 1A1, Canada.

Materials Today. Bio
|July 31, 2025
PubMed
Summary
This summary is machine-generated.

A novel dermis-on-a-chip model accurately replicates dermal fibrosis (scarring) in 3D microtissues. This platform effectively screens anti-fibrotic compounds, showing promise for improved wound healing therapies.

Keywords:
DermisFibroblastFibrosisOrgan-on-a-chipPeptide

More Related Videos

Generation of a Simplified Three-Dimensional Skin-on-a-chip Model in a Micromachined Microfluidic Platform
06:30

Generation of a Simplified Three-Dimensional Skin-on-a-chip Model in a Micromachined Microfluidic Platform

Published on: May 17, 2021

4.3K
Reconstituting Cytoarchitecture and Function of Human Epithelial Tissues on an Open-Top Organ-Chip
09:46

Reconstituting Cytoarchitecture and Function of Human Epithelial Tissues on an Open-Top Organ-Chip

Published on: February 17, 2023

1.9K

Related Experiment Videos

Last Updated: Jul 6, 2026

Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale
08:49

Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale

Published on: May 28, 2021

11.5K
Generation of a Simplified Three-Dimensional Skin-on-a-chip Model in a Micromachined Microfluidic Platform
06:30

Generation of a Simplified Three-Dimensional Skin-on-a-chip Model in a Micromachined Microfluidic Platform

Published on: May 17, 2021

4.3K
Reconstituting Cytoarchitecture and Function of Human Epithelial Tissues on an Open-Top Organ-Chip
09:46

Reconstituting Cytoarchitecture and Function of Human Epithelial Tissues on an Open-Top Organ-Chip

Published on: February 17, 2023

1.9K

Area of Science:

  • Biomedical Engineering
  • Tissue Engineering
  • Dermatology

Background:

  • Dermal fibrosis impedes wound healing due to excessive myofibroblast activation and extracellular matrix deposition.
  • Existing in vitro models like monolayer cultures and human skin equivalents (HSEs) lack physiological relevance and scalability for drug screening.
  • Developing advanced models is crucial for understanding fibrosis and identifying effective anti-fibrotic therapies.

Purpose of the Study:

  • To develop and validate a dermis-on-a-chip platform for studying dermal fibrosis.
  • To assess the platform's utility in screening anti-fibrotic compounds.
  • To investigate the effects of a regenerative peptide (Q-peptide) on fibrotic responses.

Main Methods:

  • Fabrication of a 3D dermis-on-a-chip platform housing dermal microtissues.
  • Induction of fibrotic hallmarks in microtissues using transforming growth factor beta (TGFβ).
  • Treatment of fibrotic microtissues with Q-peptide and assessment of fibrotic markers.

Main Results:

  • TGFβ treatment induced key fibrotic features: impaired integrity, increased tensile forces, altered cell morphology, and a pro-fibrotic cytokine profile.
  • Q-peptide selectively mitigated TGFβ-induced fibrotic changes.
  • Q-peptide reduced tensile forces, suppressed smooth muscle actin (SMA) expression, and modulated cytokine profiles.

Conclusions:

  • The dermis-on-a-chip platform provides a physiologically relevant model for studying dermal fibrosis.
  • This model is effective for screening anti-fibrotic compounds and understanding their mechanisms.
  • Findings highlight the potential of Q-peptide in modulating fibrotic processes for enhanced wound repair.